TGen identifies compound that could improve drug development against brain cancer

ENN
Jan 17, 2017, 4:47 pm40 pts
A study led by scientists at the Translational Genomics Research Institute (TGen) has identified "a potent inhibitory compound" in the elusive hunt for an improved treatment against glioblastoma, the most common and deadly type of adult brain cancer.Aurintricarboxylic Acid (ATA) is a chemical compound that in…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on EcoTopical

The Lucid Gravity SUV looks sold out just a day after inventory was listed online 130

Why Don’t More People Feel The Solar Industry Is Trustworthy? 127

The Key To Fossil Fuel Profits? Waste As Much Energy As Possible. 126

Physicists Reach a New Milestone in Understanding the Universe’s Fundamental Forces 125

Hong Kong prepares for 'serious threat' from Super Typhoon Ragasa 125

Heatwaves in US Rivers Increasing Up to Four Times Faster Than Air Heatwaves 121

The Hyundai IONIQ 5 N gets a new Essentials trim in Korea and a lower price tag 121

Ice Dissolves Iron Faster Than Liquid Water 120

About EcoTopical

Welcome to EcoTopical Your daily eco-friendly green news aggregator.

Leaf through planet Earths environmental headlines in one convenient place. Read, share and discover the latest on ecology, science and green living from the web's most popular sites.